KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Sales (2016 - 2025)

Historic Return on Sales for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to 476.54%.

  • Inovio Pharmaceuticals' Return on Sales rose 804300.0% to 476.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 476.54%, marking a year-over-year increase of 804300.0%. This contributed to the annual value of 495.09% for FY2024, which is 3327000.0% down from last year.
  • Per Inovio Pharmaceuticals' latest filing, its Return on Sales stood at 476.54% for Q3 2025, which was up 804300.0% from 507.16% recorded in Q2 2025.
  • Inovio Pharmaceuticals' 5-year Return on Sales high stood at 4.13% for Q3 2022, and its period low was 556.98% during Q3 2024.
  • In the last 5 years, Inovio Pharmaceuticals' Return on Sales had a median value of 243.58% in 2023 and averaged 271.39%.
  • In the last 5 years, Inovio Pharmaceuticals' Return on Sales skyrocketed by 2021400bps in 2022 and then plummeted by -4696300bps in 2024.
  • Inovio Pharmaceuticals' Return on Sales (Quarter) stood at 127.45% in 2021, then crashed by -243bps to 436.87% in 2022, then skyrocketed by 44bps to 243.58% in 2023, then surged by 32bps to 166.82% in 2024, then plummeted by -186bps to 476.54% in 2025.
  • Its Return on Sales was 476.54% in Q3 2025, compared to 507.16% in Q2 2025 and 371.0% in Q1 2025.